Literature DB >> 2427530

Oncogenes in human primary hepatic cancer.

J R Gu, L F Hu, Y C Cheng, D F Wan.   

Abstract

Transfection assay of NIH 3T3 cells was performed with DNAs isolated from ten human PHC (primary hepatic cancer) specimens and a hepatoma 7402 cell line. Positive results were obtained in 7402 and in six out of ten PHC DNAs. Human N-ras gene was identified in transfectants from 7402 DNA and transformed cells from three PHC DNA samples, which had passed more than two cycles of transfection. The expression of N-ras was also remarkably enhanced in six out of nine poly(A)+RNA samples isolated from PHC tissues. P21 synthesis was elevated in 7402 cells as well as in transfectants derived from 7402 cells and PHC DNA. In analysis of PHC DNA, rearrangement and amplification of N-ras gene was observed in two PHC samples. The discrepancy of results of the transfection assay and mRNA expression was discussed. Furthermore, c-myc was also highly expressed in most PHC tissues. It implied that the cooperating activity of N-ras and c-myc might be responsible for the malignant phenotypic alteration in some or most cases in human primary liver cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427530

Source DB:  PubMed          Journal:  J Cell Physiol Suppl        ISSN: 0737-1462


  5 in total

1.  c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver.

Authors:  Esther Baena; Alberto Gandarillas; Mireia Vallespinós; Jennifer Zanet; Oriol Bachs; Clara Redondo; Isabel Fabregat; Carlos Martinez-A; Ignacio Moreno de Alborán
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-27       Impact factor: 11.205

2.  Hypomethylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis.

Authors:  N Aiba; S Nambu; K Inoue; H Sasaki
Journal:  Gastroenterol Jpn       Date:  1989-06

3.  Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Authors:  M Tatsuta; H Iishi; M Baba; K Iseki; H Yano; H Uehara; R Yamamoto; A Nakaizumi
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

4.  Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; Y Ino; T Yoshida; M Terada
Journal:  Jpn J Cancer Res       Date:  1989-03

5.  Endogenous antibodies for tumor detection.

Authors:  Barrie S Rich; Joshua N Honeyman; David G Darcy; Peter T Smith; Andrew R Williams; Irene Isabel P Lim; Linda K Johnson; Mithat Gönen; Joel S Simon; Michael P LaQuaglia; Sanford M Simon
Journal:  Sci Rep       Date:  2014-05-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.